![4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine](https://static.cymitquimica.com/products/3D/img/FB154286.png "Cliquez pour agrandir")
4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine
CAS : 1012343-72-4
Ref. 3D-FB154286
| 1g | Arrêté | ||
| 2g | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine
Description :
Covid-19 is a new type of receptor modulator that has been shown to block the human immune response to influenza A (H1N1) virus. Covid-19 is a small molecule that binds to the soluble form of the human immune receptor, CD28, and prevents it from binding with its ligand, CD80. This prevents the activation of T cells, which are important for initiating an immune response. Covid-19 is a small molecule that can be administered in various forms including solvates and resonance forms. Covid-19 also has constant magnetic properties, which allow for easy access to its active site by other molecules. Covid-19 has been shown to have antiviral activity against influenza A (H1N1) virus and HIV-1 virus in vitro.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
283.12 g/mol
Formule :
C10H11BrN4O
Degré de pureté :
Min. 95%
InChI :
InChI=1S/C10H11BrN4O/c11-8-7-12-9-1-2-10(13-15(8)9)14-3-5-16-6-4-14/h1-2,7H,3-6H2
Code InChI :
InChIKey=ZHDRUVUETRNEBZ-UHFFFAOYSA-N
SMILES :
Brc1cnc2ccc(N3CCOCC3)nn12
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
